Empirically treating high serum thyroglobulin levels

EL Mazzaferri - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
For few tumors are there such accurate and specific tools for diagnosis and treatment as
those routinely used in the management of differentiated thyroid carcinoma (DTC). Highly …

[CITATION][C] Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?

EL Mazzaferri - The Journal of Clinical Endocrinology & …, 1995 - academic.oup.com
Serum thyroglobulin (Tg) measurements are usually the best marker of residual or
metastatic disease after the treatment of differentiated thyroid cancer. It is not rare to find …

[PDF][PDF] Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication

RL Echenique, L Kasi, TP Haynie… - Journal of Nuclear …, 1982 - Soc Nuclear Med
RESULTS Figure 1shows the levels of Tg, T4, T3, and TSH. T4 values were in the
hypothyroid range in 65 patients (96%), of which 65% showed no T4 by the assay used. The …

Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?

C Ma, J Xie, A Kuang - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential
throughout the patient's life after total or nearly total thyroidectomy followed by 131I remnant …

Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning

C Ma, A Kuang, J Xie, T Ma - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential
throughout the patient's life after total or near-total thyroidectomy followed by 131I remnant …

[PDF][PDF] Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.

EL Mazzaferri, N Massoll - Endocrine-related cancer, 2002 - erc.bioscientifica.com
The incidence of differentiated thyroid cancer (DTC) has increased in many places around
the world over the past three decades, yet this has been associated with a significant …

The changing role of radioiodine in the management of differentiated thyroid cancer

JC Reynolds, J Robbins - Seminars in nuclear medicine, 1997 - Elsevier
This article discusses several aspects of the evaluation and management of differentiated
thyroid carcinoma that are changing or may change in the near future. Although …

Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?

PW Rosario, GF Mourao, JBN dos Santos… - Thyroid, 2014 - liebertpub.com
Background: At present, empirical radioactive iodine therapy is recommended for patients
with thyroid cancer and elevated thyroglobulin (Tg) after initial therapy when neck …

Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of …

V Fatourechi, ID Hay - Seminars in nuclear medicine, 2000 - Elsevier
Differentiated thyroid cancer (DTC) patients, especially the 10% to 15% at high risk of cancer-
related death, should have long-term monitoring for detection of recurrence or metastasis …

[PDF][PDF] Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma

E Lubin, S Mechlis-Frish, S Zatz… - Journal of Nuclear …, 1994 - Soc Nuclear Med
MATERIALSAND METhODS For 12yr since 1981, 261patientswere followedby periodic
determination of thyrO&JObUIinunder replacement therapy. The population studied (Table …